Medicina Interna e Clinical Governance: quali proposte per il prossimo futuro?
Submitted: 22 December 2014
Accepted: 22 December 2014
Published: 22 December 2014
Accepted: 22 December 2014
Abstract Views: 3596
PDF: 3384
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Giancarlo Landini, Luca Masotti, Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists , Italian Journal of Medicine: Vol. 7 No. s8 (2013): The new oral anticoagulants in the Internal Medicine clinical practice
- Mohammed Almansori, Quadricuspid aortic valve , Italian Journal of Medicine: Vol. 7 No. 1 (2013)
- Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli, Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation , Italian Journal of Medicine: Vol. 7 No. s8 (2013): The new oral anticoagulants in the Internal Medicine clinical practice
<< < 30 31 32 33 34 35 36 37 38 39 40
You may also start an advanced similarity search for this article.